ATE328100T1 - Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren - Google Patents

Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren

Info

Publication number
ATE328100T1
ATE328100T1 AT95941756T AT95941756T ATE328100T1 AT E328100 T1 ATE328100 T1 AT E328100T1 AT 95941756 T AT95941756 T AT 95941756T AT 95941756 T AT95941756 T AT 95941756T AT E328100 T1 ATE328100 T1 AT E328100T1
Authority
AT
Austria
Prior art keywords
transcomplementation
cell line
packaging cell
retrovirus vectors
defective retrovirus
Prior art date
Application number
AT95941756T
Other languages
English (en)
Inventor
Odile Cohen-Haguenauer
Original Assignee
Odile Cohen-Haguenauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Odile Cohen-Haguenauer filed Critical Odile Cohen-Haguenauer
Application granted granted Critical
Publication of ATE328100T1 publication Critical patent/ATE328100T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/17011—Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17051—Methods of production or purification of viral material
    • C12N2740/17052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Circuits Of Receivers In General (AREA)
  • Character Discrimination (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photovoltaic Devices (AREA)
  • Semiconductor Memories (AREA)
AT95941756T 1994-11-30 1995-11-30 Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren ATE328100T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414406A FR2727429B1 (fr) 1994-11-30 1994-11-30 Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs

Publications (1)

Publication Number Publication Date
ATE328100T1 true ATE328100T1 (de) 2006-06-15

Family

ID=9469343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941756T ATE328100T1 (de) 1994-11-30 1995-11-30 Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren

Country Status (10)

Country Link
US (1) US6432709B1 (de)
EP (1) EP0796338B1 (de)
JP (1) JPH10510163A (de)
AT (1) ATE328100T1 (de)
AU (1) AU4306996A (de)
CA (1) CA2206574A1 (de)
DE (1) DE69535024D1 (de)
FR (1) FR2727429B1 (de)
IL (1) IL116216A (de)
WO (1) WO1996017071A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997035995A1 (fr) * 1996-03-25 1997-10-02 Transgene S.A. Compositions cellulaires antitumorales exprimant au moins trois transgenes
WO1997035996A1 (en) * 1996-03-25 1997-10-02 Transgene S.A. Packaging cell line based on human 293 cells
FR2751345B1 (fr) 1996-07-16 1998-09-18 Univ Paris Curie Lignees d'encapsidation hautement productrices
EP0975783B1 (de) 1997-02-27 2001-10-31 Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Retrovirale vektoren, verfahren zu ihrer herstellung und ihre verwendung zur genübertragung in cd4-positive zellen
EP1056478A4 (de) * 1998-01-21 2001-12-05 Univ Michigan Technology Man W Zielgerichteter transfer von genvektoren in bestimmte zelltypen durch pseudotyping mit viralem glykoprotein

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650764A (en) * 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
ATE142268T1 (de) 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer Retroviraler vektor
AU4307589A (en) * 1988-09-15 1990-04-02 North Carolina State University Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
AU7312891A (en) 1990-02-12 1991-09-03 Board Of Regents, The University Of Texas System Satellite cell proliferation in adult skeletal muscle
CA2092195C (en) * 1990-09-21 2000-04-18 Douglas J. Jolly Retroviral packaging cell line
US5643756A (en) 1992-08-28 1997-07-01 The Public Health Research Institute Of The City Of New York, Inc. Fusion glycoproteins
EP0611822B1 (de) * 1993-02-17 2002-05-22 Wisconsin Alumni Research Foundation Retroviren vom Typ "more-complex", die LTR von gemischtem Typ enthalten und deren Anwendungen
DE4318387A1 (de) * 1993-06-03 1994-12-08 Bayer Ag Rekombinante Foamy Virus Vektoren für medizinische und diagnostische Anwendungen sowie Verfahren zur Herstellung von rekombinanten Foamy Virus Vektoren
FR2707091B1 (fr) * 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.

Also Published As

Publication number Publication date
EP0796338A1 (de) 1997-09-24
FR2727429A1 (fr) 1996-05-31
WO1996017071A1 (fr) 1996-06-06
AU4306996A (en) 1996-06-19
DE69535024D1 (de) 2006-07-06
FR2727429B1 (fr) 1997-11-28
JPH10510163A (ja) 1998-10-06
IL116216A (en) 2007-02-11
EP0796338B1 (de) 2006-05-31
CA2206574A1 (fr) 1996-06-06
IL116216A0 (en) 1996-01-31
US6432709B1 (en) 2002-08-13

Similar Documents

Publication Publication Date Title
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
MY125594A (en) Immortalized cell lines for virus growth
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
BR0009362A (pt) Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
EA199800566A1 (ru) Аденовирусный вектор (варианты), способ его получения, применение, репликационно-компетентное не содержащее аденовирус потомство, способ повышения размножения в комплементирующей клеточной линии аденовирусного вектора, способ генетической модификации клетки, композиция, клетка-хозяин, способ тестирования токсичности аденовирусного вектора, способ тестирования экспрессии чужеродного гена или гена-пассажира аденовирусного вектора
HUP9900050A1 (hu) Rekombináns adenovírusok, és felhasználásuk adeno-asszociált vírusok (AAV) előállítására, komplementáló sejtvonalak, és az illető adenovírusokat tartalmazó gyógyszerkészítmények
ATE328095T1 (de) Verbesserungen des stärkegehaltes von pflanzen
WO2002002783A3 (en) Expression vectors
NZ500791A (en) Gene transfer with adenoviruses having modified fiber proteins
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
ES2118140T3 (es) Procedimiento de modificacion genetica de las celulas de la medula osea de primates, y celulas utilizables y celulas que producen vectores retrovirales recombinados.
WO2001004282A3 (en) Replication-competent anti-cancer vectors
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
WO1999028488A3 (de) Retrovirale pseudotyp-vektoren mit modifizierten oberflächen-hüllproteinen und verfahren zu ihrer herstellung für den selektiven gentransfer
ATE386130T1 (de) Adenovirale vektoren für die gentherapie
ATE328100T1 (de) Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren
CY1108619T1 (el) Πρωτεϊνη σπονδυλωτων patched-2
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
ES2184059T3 (es) Vector retrovirico y su utilizacion en terapia genica.
FR2778670B1 (fr) Methodes et compositions pour la production de particules virales
FI945877A0 (fi) Menetelmä proteiini C:n tuottamiseksi
CA2146240A1 (en) Increased production of secreted proteins by recombinant eukaryotic cells
Sakurai et al. Subunit composition of RNA polymerase II from the fission yeast Schizosaccharomyces pombe
ATE96838T1 (de) Expressionsvektor und verfahren zur expression von heterologen proteinen in saeugerzellen.
DK0994955T3 (da) Öget produktion af secernerede proteiner med rekombinante gærceller

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties